New test could help 40 000 pregnant rhesus D negative women avoid treatment, says NICEBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i3944 (Published 15 July 2016) Cite this as: BMJ 2016;354:i3944
- Zosia Kmietowicz
- The BMJ
A new test that identifies which pregnant women who are rhesus D negative need to be treated could save the NHS £500 000 (€600 000; $666 000) a year.
Draft guidance from the National Institute for Health and Care Excellence (NICE)1 recommends that only those women who are rhesus D negative and carrying a rhesus D positive baby should be treated with anti-D immunoglobulin. If the proposal is adopted, treatment could be avoided in 40 000 women, NICE has said.
Currently, all women who are rhesus …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial